Skip to main content
Log in

Theoretical Design of Prodrug-Enhancer Combination Based on a Skin Diffusion Model: Prediction of Permeation of Acyclovir Prodrugs Treated with l-Geranylazacycloheptan-2-one

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. A theoretical design of percutaneous penetration enhancement in which prodrug derivation and enhancer application are combined is proposed based on the skin diffusion model and it is experimentally verified.

Methods. Employing acyclovir as a model drug, the hypothesis was tested by synthesis of its prodrugs and evaluation of their in vitro permeation in the rat skin, with or without a penetration enhancer, 1-geranylazacycloheptan-2-one(GACH).

Results. Among five acyclovir prodrugs, those with higher lipophilicit-ies (propionate, butyrate, valerate, and hexanoate prodrugs) showed greater skin penetration than those of hydrophilic prodrugs (acetate), when administered in combination with GACH. Furthermore, the observed enhancement ratios were in good agreement with those predicted by theoretical consideration.

Conclusions. Thus, skin permeation of prodrugs applied with an enhancer can be predicted and optimized by model analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. A. C. Williams and B. W. Barry. The enhancement index concept applied to terpens penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs. Int. J. Pharm. 74:157–168 (1991).

    Google Scholar 

  2. K. B. Sloan. Prodrugs: Topical and Ocular Drug Delivery, Marcel Dekker Inc., New York, 1992.

    Google Scholar 

  3. P. G. Green, R. S. Hinz, A. Kim, F. C. Szoka, and R. H. Guy. Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm. Res. 8:1121–1127 (1991).

    Google Scholar 

  4. W. M. Shannon, L. Westbrook, W. I. Higuchi, K. Sugibayashi, D. C. Baker, S. D. Kumar, J. L. Fox, G. L. Flynn, N. F. H. Ho, and R. Vaidyanathan. Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2′,3′-di-o-acetyl-9-β-d-arabinofuranosyladenine and 5′-o-valeryl-9-β-d-arabinofuranosyladenine. J. Pharm. Sci. 74:1157–1161 (1985).

    Google Scholar 

  5. H. Okamoto, F. Yamashita, K. Saito, and M. Hashida. Analysis of drug penetration through the skin by the two layer skin diffusion model. Pharm. Res. 6:931–937 (1989).

    Google Scholar 

  6. A. H. Ghanem, H. Mahmoud, W. I. Higuchi, U. D. Rohr, S. Borsadia, P. Liu, J. L. Fox, and W. R. Good. The effects of ethanol on the transport of β-estradiol and other permeants in hairless mouse skin. II. A new quantitative approach. J. Controlled Release. 6:75–83 (1987).

    Google Scholar 

  7. F. Yamashita, T. Yoshioka, Y. Koyama, H. Okamoto, H. Sezaki, and M. Hashida. Analysis of skin penetration enhancement based on a two-layer skin diffusion model with polar and nonpolar routes in the stratum corneum: Dose-dependent effect of 1-geranylazacycloheptan-2-one on drugs with different lipophilicities. Biol. Pharm. Bull. 16:690–697 (1993).

    Google Scholar 

  8. Y. Yano, K. Yamaoka, and H. Tanaka. A nonlinear least squares program, MULTI(FILT), based on fast inverse Laplace transform for microcomputers. Chem. Pharm. Bull. 37:1035–1038 (1989).

    Google Scholar 

  9. A. Leo, C. Hansch, and D. Elkins. Partition coefficients and their uses. Chem. Rev. 71:525 (1971).

    Google Scholar 

  10. C. Ackermann and G. L. Flynn. Ether-water partitioning and permeability through nude mouse skin in vitro. I Urea, thiourea, glycerol and glucose. Int. J. Pharm. 36:61–66 (1987).

    Google Scholar 

  11. F. Yamashita, H. Bando, Y. Koyama, S. Kitagawa, Y. Takakura, and M. Hashida. In vivo and in vitro analysis of skin penetration enhancement based on a two-layer diffusion model with polar and nonpolar routes in the stratum corneum. Pharm. Res. 11:185–191 (1994).

    Google Scholar 

  12. H. Bundgaard, E. Jensen, and E. Falch. Water-soluble, solution-stable, and biolabile n-substituted (aminomethyl) benzoate ester prodrugs of acyclovir. Pharm. Res. 8:1087–1093 (1990).

    Google Scholar 

  13. H. Bando, F. Yamashita, Y. Takakura, and M. Hashida. Skin penetration enhancement of acyclovir by prodrug-enhancer combination. Biol. Pharm. Bull. 17:1141–1143 (1994).

    Google Scholar 

  14. Z. Shao, G. B. Park, R. Krishnamoorthy, and A. K. Mitra. The physicochemical properties, plasma enzymatic hydrolysis, and nasal absorption of acyclovir and its 2′-ester prodrugs. Pharm. Res. 11:237–242 (1994).

    Google Scholar 

  15. P. Liu, W. I. Higuchi, A. H. Ghanem, and W. R. Good. Transport of b-estradiol in Freshly Excised Human Skin in Vitro: Diffusion and Metabolism in Each Skin Layer. Pharm. Res. 11:1777–1784 (1994).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bando, H., Takagi, T., Yamashita, F. et al. Theoretical Design of Prodrug-Enhancer Combination Based on a Skin Diffusion Model: Prediction of Permeation of Acyclovir Prodrugs Treated with l-Geranylazacycloheptan-2-one. Pharm Res 13, 427–432 (1996). https://doi.org/10.1023/A:1016000827719

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016000827719

Navigation